Zejula has been recommended for use in newly diagnosed ovarian cancer patients
Zejula has been recommended for use in newly diagnosed ovarian cancer patients
In a Phase IIb trial, more patients experienced complete resolution of hives with ligelizumab compared to Xolair
Qualified pharmacists will administer the Pfizer/BioNTech vaccine at an in-store pharmacy
First dispersible tablet formulation of Tivicay now available for children in the EU
Oxford Immunotec will perform T cell testing on participants receiving Valneva’s vaccine candidate
Companies will collaborate on a combination therapy study
Updated analysis is from the Phase III IMbrave150 study
MHRA submission is based on same application filed with the EMA
Investigational antibody targets a modified form of beta amyloid called N3pG
First patient in global trial dosed in the UK
Study will evaluate the role of smart devices on monitoring cognitive health
CCS1477 has a novel mechanism of action compared to existing treatments
Framework identifies four key priorities and five ‘underpinning themes’
Plan aims to rapidly scale-up COVID-19 vaccination programme
Partnership will aim to research and implement quantum computing in pharma R&D